Combined p-tau217 + p-tau231 Panel Increases Specificity for Treatment Cessatio…

Mechanistic description

p-tau231 reflects earlier amyloid-driven changes in entorhinal cortex while p-tau217 reflects downstream neuronal involvement. The combination captures the full spectrum of amyloid-to-tau propagation resolution. However, the composite algorithm is not operationally defined, weighting schemes are unspecified, and temporal window evidence from natural disease course may not transfer to treatment kinetics. Addition of p-tau231 may increase assay complexity without proportional predictive gain.

Mechanism / pathway

NA - Multi-biomarker diagnostic
→
neurodegeneration

Evidence for (7)

p-tau231 increases earlier in Alzheimer's course than p-tau217

PMID:37266949
Combination of plasma p-tau217/p-tau231 ratio improves discrimination of amyloid status

PMID:36566449
Clustering of Tau fibrils impairs the synaptic composition of α3-Na(+)/K(+)-ATPase and AMPA receptors.

PMID:30630857 2019 EMBO J
Mutant Tau protein-induced abnormalities in the Na(+)-dependent glutamine translocation and recycling and their impact on astrocyte-neuron integrity in vitro.

PMID:37295680 2023 Neurochem Int
Cell biology and dynamics of Neuronal Na(+)/K(+)-ATPase in health and diseases.

PMID:30550795 2020 Neuropharmacology
Disease-specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease.

PMID:40501099 2025 Alzheimers Dement
Biophysical characterization of the Varroa destructor Na(V)1 sodium channel and its affinity for τ-fluvalinate insecticide.

PMID:28356346 2017 FASEB J

Evidence against (2)

Combination improves amyloid status discrimination, not treatment cessation outcomes

PMID:36566449
p-tau231 may be more confounded by non-AD amyloid pathology (CAA, LBD)

PMID:NA

Evidence matrix

7 supporting 2 contradicting

78% supporting

Supporting

p-tau231 increases earlier in Alzheimer's course than p-tau217 PMID:37266949
Combination of plasma p-tau217/p-tau231 ratio improves discrimination of amyloid status PMID:36566449
Clustering of Tau fibrils impairs the synaptic composition of α3-Na(+)/K(+)-ATPase and AMPA receptors. PMID:30630857 · 2019 · EMBO J
Mutant Tau protein-induced abnormalities in the Na(+)-dependent glutamine translocation and recycling and their impact on astrocyte-neuron integrity in vitro. PMID:37295680 · 2023 · Neurochem Int
Cell biology and dynamics of Neuronal Na(+)/K(+)-ATPase in health and diseases. PMID:30550795 · 2020 · Neuropharmacology
Disease-specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease. PMID:40501099 · 2025 · Alzheimers Dement
Biophysical characterization of the Varroa destructor Na(V)1 sodium channel and its affinity for τ-fluvalinate insecticide. PMID:28356346 · 2017 · FASEB J

Contradicting

Combination improves amyloid status discrimination, not treatment cessation outcomes PMID:36566449
p-tau231 may be more confounded by non-AD amyloid pathology (CAA, LBD) PMID:NA

Cite this hypothesis

Citation

etl-backfill (2026). Combined p-tau217 + p-tau231 Panel Increases Specificity for Treatment Cessatio…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-9d2bca0f28

BibTeX

@misc{scidex_hypothesis_h9d2bca0,
  title        = {Combined p-tau217 + p-tau231 Panel Increases Specificity for Treatment Cessatio…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-9d2bca0f28},
  note         = {SciDEX artifact hypothesis:h-9d2bca0f28}
}